- 期刊
Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case Presentation
延伸閱讀
- Wu, C. T., Lai, C. H., Hung, C. H., Liu, K. C., Chen, M. F., & Chen, W. C. (2014). Preliminary Results of Biochemical Outcomes, Survival and Toxicity in Patients Treated with Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. 放射治療與腫瘤學, 21(1), 1-12. https://doi.org/10.6316/TRO/201421(1)1
- Lan, K. H., Chen, Y. H., Wu, J. K., Hsu, F. M., Wang, C. W., & Cheng, C. H. (2010). The Prognostic Factors and Short-Term Outcome of Intensity-Modulated Radiotherapy for Patients with Prostatic Adenocarcinoma. 放射治療與腫瘤學, 17(1), 9-18. https://doi.org/10.6316/TRO/201017(1)9
- Fu, Y. T., Wang, H. H., Lee, S. S., Sun, G. H., Cheng, C. L., Fong, C. J., Yang, T. H., Ma, C. P., Chang, S. Y., & Yu, D. S. (1996). Changes in Serum Prostate-Specific Antigen after Orchiectomy and Complete Androgen Blockade in Patients with Stage D Prostatic Carcinoma. 中華民國泌尿科醫學會雜誌, 7(1), 30-33. https://doi.org/10.7024/JUAROC.199603.0030
- TAKAMORI, H., HIRAOKA, T., KANEMITSU, K., TSUJI, T., SAITO, N., NISHIDA, H., SAKAGUCHI, H., & MIYAUCHI, Y. (1994). Treatment Strategies for Hepatic Metastases from Pancreatic Cancer in Patients Previously Treated with Radical Resection Combined with Intraoperative Radiation Therapy. HPB Surgery, 1994(), 107-110. https://doi.org/10.1155/1994/61323
- Wu, J. C. H., Chang, D. S., & Lin, M. S. (2006). The Use of Serum Free-To-Total Prostate Specific Antigen Ratio to Predict Pathological Stage and Gleason Grade of Prostate Cancer with PSA of 4-20 ng/ml. 秀傳醫學雜誌, 6(1&2), 1-8. https://www.airitilibrary.com/Article/Detail?DocID=15610497-200604-6-1&2-1-8-a